Published in J Vasc Surg on February 01, 2007
Mesenteric revascularization: management and outcomes in the United States, 1988-2006. J Vasc Surg (2009) 1.58
Diagnosis and management of splanchnic ischemia. World J Gastroenterol (2008) 0.99
Acute mesenteric ischemia after cardio-pulmonary bypass surgery. World J Gastroenterol (2008) 0.97
A review of surgically treated patients with obstruction after stenting in the femoropopliteal artery region. Ann Vasc Dis (2013) 0.78
Hybrid technique to treat superior mesenteric artery occlusion in patients with acute mesenteric ischemia. Exp Ther Med (2015) 0.75
Pre-operative endovascular stenting of the coeliac trunk. Ann R Coll Surg Engl (2008) 0.75
Endovascular recanalisation of an acute superior mesenteric artery occlusion. A case report and review of the literature. Ann Med Surg (Lond) (2014) 0.75
Diagnosis of non-occlusive acute mesenteric ischemia in the intensive care unit. Ann Intensive Care (2016) 0.75
Primary Endovascular Intervention for Acute Mesenteric Ischemia Performed by Interventional Cardiologists - A Single Center Experience. Acta Cardiol Sin (2017) 0.75
A regional registry for quality assurance and improvement: the Vascular Study Group of Northern New England (VSGNNE). J Vasc Surg (2007) 2.96
Derivation and validation of a practical risk score for prediction of mortality after open repair of ruptured abdominal aortic aneurysms in a US regional cohort and comparison to existing scoring systems. J Vasc Surg (2012) 2.78
The effect of postoperative myocardial ischemia on long-term survival after vascular surgery. J Vasc Surg (2013) 2.72
Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. J Vasc Surg (2003) 2.71
Factors associated with stroke or death after carotid endarterectomy in Northern New England. J Vasc Surg (2008) 2.22
Regional variation in carotid artery stenting and endarterectomy in the Medicare population. Circ Cardiovasc Qual Outcomes (2009) 2.21
Optimal selection of asymptomatic patients for carotid endarterectomy based on predicted 5-year survival. J Vasc Surg (2013) 2.16
The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore) (2002) 2.10
Thoracic endovascular aneurysm repair, race, and volume in thoracic aneurysm repair. J Vasc Surg (2012) 2.07
Withdrawal of article by the FDA after objection from Medtronic. J Vasc Surg (2004) 2.04
Intraoperative use of dextran is associated with cardiac complications after carotid endarterectomy. J Vasc Surg (2013) 2.02
Survival after open versus endovascular thoracic aortic aneurysm repair in an observational study of the Medicare population. Circulation (2011) 2.00
Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet (2003) 1.98
Screening for abdominal aortic aneurysm: a consensus statement. J Vasc Surg (2004) 1.96
Regulation of vascular smooth muscle cell differentiation. J Vasc Surg (2007) 1.92
In vivo analysis of mechanical wall stress and abdominal aortic aneurysm rupture risk. J Vasc Surg (2002) 1.92
Factors associated with death 1 year after lower extremity bypass in Northern New England. J Vasc Surg (2009) 1.86
Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg (2009) 1.81
Infliximab in the treatment of refractory posterior uveitis. Ophthalmology (2003) 1.75
Impact of screening versus symptomatic measurement of deep vein thrombosis in a national quality improvement registry. J Vasc Surg (2012) 1.63
A regional quality improvement effort to increase beta blocker administration before vascular surgery. J Vasc Surg (2011) 1.61
The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation. Am J Physiol Cell Physiol (2003) 1.57
Carotid endarterectomy in asymptomatic patients with limited life expectancy. Stroke (2012) 1.54
Outcomes and practice patterns in patients undergoing lower extremity bypass. J Vasc Surg (2012) 1.53
Impact of practice patterns in shunt use during carotid endarterectomy with contralateral carotid occlusion. J Vasc Surg (2011) 1.53
Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes. Arthritis Rheum (2003) 1.51
Carotid artery stenting and patient outcomes: the CABANA surveillance study. Catheter Cardiovasc Interv (2014) 1.45
Predicting 1-year mortality after elective abdominal aortic aneurysm repair. J Vasc Surg (2009) 1.43
Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt2 feedback signaling. J Biol Chem (2007) 1.35
The Vascular Study Group of New England Cardiac Risk Index (VSG-CRI) predicts cardiac complications more accurately than the Revised Cardiac Risk Index in vascular surgery patients. J Vasc Surg (2010) 1.34
Anatomic characteristics of ruptured abdominal aortic aneurysm on conventional CT scans: Implications for rupture risk. J Vasc Surg (2004) 1.34
Isolated dissection of the abdominal aorta: clinical presentation and therapeutic options. J Vasc Surg (2002) 1.28
Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol (2006) 1.26
Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther (2004) 1.23
Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour. Immunology (2004) 1.22
National trends and regional variation of open and endovascular repair of thoracic and thoracoabdominal aneurysms in contemporary practice. J Vasc Surg (2011) 1.22
Acceleration of cardiovascular disease by a dysfunctional prostacyclin receptor mutation: potential implications for cyclooxygenase-2 inhibition. Circ Res (2008) 1.17
Validation of the Society for Vascular Surgery's objective performance goals for critical limb ischemia in everyday vascular surgery practice. J Vasc Surg (2011) 1.16
Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function. Arthritis Rheum (2006) 1.16
Prior failed ipsilateral percutaneous endovascular intervention in patients with critical limb ischemia predicts poor outcome after lower extremity bypass. J Vasc Surg (2011) 1.13
The prostacyclin receptor induces human vascular smooth muscle cell differentiation via the protein kinase A pathway. Am J Physiol Heart Circ Physiol (2006) 1.12
Factors associated with amputation or graft occlusion one year after lower extremity bypass in northern New England. Ann Vasc Surg (2009) 1.09
Failure to achieve clinical improvement despite graft patency in patients undergoing infrainguinal lower extremity bypass for critical limb ischemia. J Vasc Surg (2010) 1.08
Mesenteric stenting for chronic mesenteric ischemia. J Vasc Surg (2005) 1.08
Restenosis after carotid endarterectomy in a multicenter regional registry. J Vasc Surg (2010) 1.06
Shedding of mutant tumor necrosis factor receptor superfamily 1A associated with tumor necrosis factor receptor-associated periodic syndrome: differences between cell types. Arthritis Rheum (2004) 1.06
Adiponectin induces vascular smooth muscle cell differentiation via repression of mammalian target of rapamycin complex 1 and FoxO4. Arterioscler Thromb Vasc Biol (2011) 1.05
Protamine reduces bleeding complications associated with carotid endarterectomy without increasing the risk of stroke. J Vasc Surg (2010) 1.04
Choice of vascular surgery as a specialty: survey of vascular surgery residents, general surgery chief residents, and medical students at hospitals with vascular surgery training programs. J Vasc Surg (2004) 1.03
Outcomes of symptomatic abdominal aortic aneurysm repair. J Vasc Surg (2010) 1.02
Mutant tumor necrosis factor receptor associated with tumor necrosis factor receptor-associated periodic syndrome is altered antigenically and is retained within patients' leukocytes. Arthritis Rheum (2007) 1.01
Predicting ambulation status one year after lower extremity bypass. J Vasc Surg (2009) 1.01
Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease. J Vasc Surg (2008) 1.00
Early discharge does not increase readmission or mortality after high-risk vascular surgery. J Vasc Surg (2012) 1.00
Neuroprotection during carotid artery stenting using the GORE flow reversal system: 30-day outcomes in the EMPiRE Clinical Study. Catheter Cardiovasc Interv (2010) 1.00
Optimal selection of patients for elective abdominal aortic aneurysm repair based on life expectancy. J Vasc Surg (2013) 0.99
Role of interleukin-6 in a patient with tumor necrosis factor receptor-associated periodic syndrome: assessment of outcomes following treatment with the anti-interleukin-6 receptor monoclonal antibody tocilizumab. Arthritis Rheum (2011) 0.99
Endovascular repair of abdominal aortic aneurysm without preoperative arteriography. J Vasc Surg (2003) 0.99
Comparison of carotid endarterectomy and stenting in real world practice using a regional quality improvement registry. J Vasc Surg (2012) 0.98
Endothelial cell activation of the smooth muscle cell phosphoinositide 3-kinase/Akt pathway promotes differentiation. J Vasc Surg (2005) 0.96
Predicting functional status following amputation after lower extremity bypass. Ann Vasc Surg (2012) 0.95
Reactivation of Epstein-Barr virus in patients with systemic lupus erythematosus. Rheumatol Int (2003) 0.94
Outcomes of renal artery angioplasty and stenting using low-profile systems. J Vasc Surg (2005) 0.92
Variation in smoking cessation after vascular operations. J Vasc Surg (2013) 0.92
Prevalence and clinical significance of stent fracture and deformation following carotid artery stenting. J Vasc Surg (2011) 0.92
Clopidogrel is not associated with major bleeding complications during peripheral arterial surgery. J Vasc Surg (2011) 0.92
The eye in systemic inflammatory diseases. Lancet (2004) 0.91
Long-term results of open and endovascular revascularization of superficial femoral artery occlusive disease. J Vasc Surg (2011) 0.91
Shared quality data are associated with increased protamine use and reduced bleeding complications after carotid endarterectomy in the Vascular Study Group of New England. J Vasc Surg (2013) 0.91
Novel markers of inflammation identified in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line. Arthritis Rheum (2009) 0.91
A pro-inflammatory signalome is constitutively activated by C33Y mutant TNF receptor 1 in TNF receptor-associated periodic syndrome (TRAPS). Eur J Immunol (2014) 0.90
Blood transfusion for lower extremity bypass is associated with increased wound infection and graft thrombosis. J Am Coll Surg (2013) 0.90
The effect of risk and race on lower extremity amputations among Medicare diabetic patients. J Vasc Surg (2012) 0.89
Disseminated Mycobacterium tuberculosis infection due to interferon gamma deficiency. Response to replacement therapy. Thorax (2007) 0.89